全球開放式、一體化生物制藥能力和技術賦能平臺,專注于為全球生物制藥公司提供端到端研發服務的上市公司
藥明生(sheng)(sheng)(sheng)(sheng)(sheng)(sheng)物(wu)(wu)(wu)(股(gu)票代(dai)碼:2269.HK)作為(wei)一家(jia)香港上(shang)市公(gong)(gong)(gong)司(si)(si),是全(quan)(quan)球(qiu)開放式(shi)、一體化生(sheng)(sheng)(sheng)(sheng)(sheng)(sheng)物(wu)(wu)(wu)制藥能力(li)(li)和技術(shu)賦能平(ping)臺。公(gong)(gong)(gong)司(si)(si)為(wei)全(quan)(quan)球(qiu)生(sheng)(sheng)(sheng)(sheng)(sheng)(sheng)物(wu)(wu)(wu)制藥公(gong)(gong)(gong)司(si)(si)和生(sheng)(sheng)(sheng)(sheng)(sheng)(sheng)物(wu)(wu)(wu)技術(shu)公(gong)(gong)(gong)司(si)(si)提(ti)供端到(dao)(dao)端研(yan)發(fa)服(fu)務,幫助任何人(ren)、任何公(gong)(gong)(gong)司(si)(si)發(fa)現、開發(fa)及生(sheng)(sheng)(sheng)(sheng)(sheng)(sheng)產生(sheng)(sheng)(sheng)(sheng)(sheng)(sheng)物(wu)(wu)(wu)藥,實(shi)現從概念(nian)到(dao)(dao)商業化生(sheng)(sheng)(sheng)(sheng)(sheng)(sheng)產的(de)全(quan)(quan)過程,加速(su)全(quan)(quan)球(qiu)生(sheng)(sheng)(sheng)(sheng)(sheng)(sheng)物(wu)(wu)(wu)藥研(yan)發(fa)進程,降低研(yan)發(fa)成本,造福病患(huan)。截至2018年(nian)12月31日,在藥明生(sheng)(sheng)(sheng)(sheng)(sheng)(sheng)物(wu)(wu)(wu)平(ping)臺上(shang)研(yan)發(fa)的(de)綜合項(xiang)目達205個(ge),包括97個(ge)處于臨床前研(yan)究階段(duan),94個(ge)在臨床早期(I期,II期)階段(duan),13個(ge)在后期臨床(III期)以及1個(ge)在商業化生(sheng)(sheng)(sheng)(sheng)(sheng)(sheng)產階段(duan)。預計(ji)到(dao)(dao)2022年(nian),公(gong)(gong)(gong)司(si)(si)在中國、愛爾蘭、新加坡、美(mei)國規(gui)劃(hua)的(de)生(sheng)(sheng)(sheng)(sheng)(sheng)(sheng)物(wu)(wu)(wu)制藥生(sheng)(sheng)(sheng)(sheng)(sheng)(sheng)產基地(di)合計(ji)產能約22萬升,這將有力(li)(li)促使公(gong)(gong)(gong)司(si)(si)通過健全(quan)(quan)強大的(de)全(quan)(quan)球(qiu)供應鏈網(wang)絡為(wei)客(ke)戶提(ti)供符(fu)合全(quan)(quan)球(qiu)質量(liang)標準的(de)生(sheng)(sheng)(sheng)(sheng)(sheng)(sheng)物(wu)(wu)(wu)藥。
藥(yao)明生(sheng)(sheng)物是(shi)全(quan)球(qiu)開放式、一體(ti)化生(sheng)(sheng)物制(zhi)藥(yao)能(neng)力和(he)技術賦(fu)能(neng)平臺(tai)。公(gong)司(si)為全(quan)球(qiu)生(sheng)(sheng)物制(zhi)藥(yao)公(gong)司(si)和(he)生(sheng)(sheng)物技術公(gong)司(si)提供端到端研發服(fu)(fu)務,幫(bang)助任何人、任何公(gong)司(si)發現、開發及生(sheng)(sheng)產生(sheng)(sheng)物藥(yao),實現從概念到商業化生(sheng)(sheng)產的(de)全(quan)過(guo)程(cheng)。公(gong)司(si)通(tong)過(guo)高(gao)(gao)質量、一體(ti)化服(fu)(fu)務賦(fu)能(neng)全(quan)球(qiu)客戶(hu),提高(gao)(gao)研發效率,降低研發成本,進一步加速生(sheng)(sheng)物藥(yao)研發進程(cheng)。